Please login to the form below

Not currently logged in
Email:
Password:

Blue Rubicon

This page shows the latest Blue Rubicon news and features for those working in and with pharma, biotech and healthcare.

Controversial pancreatic cancer campaign wins award

Controversial pancreatic cancer campaign wins award

Sainsbury's, Sainsbury's by AMV BBDO, Blue Rubicon, PHD Media and Sainsbury's.

Latest news

  • Blue Rubicon buys Open Road Blue Rubicon buys Open Road

    We're bringing together two independent consultancies with a similar mind-set, approach, reputation and strategic communications offer,” said Blue Rubicon CEO, Gordon Tempest Hay. ... While forming part of the Blue Rubicon family, Open Road will

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Firstlight appoints three new directors Firstlight appoints three new directors

    All three joined Firstlight having excelled in leading agencies, Sam from Blue Rubicon, Anna from Cohn and Wolfe and Grant from Ruder Finn.

  • Edelman strengthens healthcare team Edelman strengthens healthcare team

    Dalton moves to the agency from Blue Rubicon, where she was a senior consultant, and also brings experience from Ogilvy &Mather and Weber Shandwick, where she most recently served as an

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Our latest additions Our latest additions

    The new team members are:. Sam Bevans With 18 years’ communications experience, including senior roles at freuds and Blue Rubicon, Sam joins Aurora as a Director.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics